Latest Updates - Page 227 of 1528 - Express Pharma

PROTACs oncology market to hit $3.7 billion by 2030 despite lack of approved therapies: GlobalData

Nidlegy Marketing Authorization Application Submitted to EMA

PharmaLytica 2024: charting India’s pharma’s path to USD 130 billion by 2030 from the powerhouse hub of Hyderabad

Pharma funding sees volatile shifts in May 2024

PURIFY’24 West to mark its 5th edition of PURIFY conferences

Aurigene Pharma announces the opening of its biologics facility

Lupin receives tentative approval from U.S. FDA for Letermovir tablets

Bionova Scientific announces $100 million investment in new Plasmid DNA facility

Moderna receives U.S. FDA approval for RSV vaccine mRESVIA(R)

Lupin launches Doxycycline for Injection USP in the United States